Entero Healthcare Q4 consolidated profit Rs 451.28 million; board approves acquisition
Entero Healthcare Solutions · Retailing
Key highlights
- Consolidated profit for the quarter ended March 31, 2026 was Rs 451.28 million against Rs 314.22 million a year earlier; revenue was Rs 19,099.27 million against Rs 13,390.56 million.
- Board approved acquisition of Vishal Surgicals and Vishal Surgicals & Medicals through subsidiary Sai Pharma Distributors Private Limited by slump sale/BTA; no amount is given in the text.
- Three independent directors re-appointed for five years from August 25, 2026, subject to shareholder approval; 7,300 employee stock options granted.
Why it's rated notable: the year-on-year change is 44% (20% to 50%)
Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.
Original filing
Announcement under Regulation 30 (LODR)-Allotment
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Entero Healthcare Solutions
- Acquisition / mergerNotableEntero Healthcare FY26 results; 7,300 ESOPs granted; 3 director re-appointments proposed
- Acquisition / mergerNotableEntero Healthcare to acquire Vishal Surgicals; reappoints 3 directors; grants 7,300 ESOPs
- Acquisition / mergerNotableEntero Healthcare reports FY26 results, grants 7,300 ESOPs and acquires Vishal Surgicals
- Acquisition / mergerNotableEntero Healthcare Q4 FY26 consolidated profit Rs 451.28 million vs Rs 314.22 million
- Acquisition / mergerNotableEntero Healthcare posts FY26 audited results; approves Vishal Surgicals acquisition
Other fundraise / allotment filings this fortnight
- Supreme Engineering allots 14,50,00,000 warrants at ₹2.60 on preferential basis
- Bajaj Finance Limited allots 5.74 crore warrants to Bajaj Finserv on 10 Nov 2026
- Bajaj Finance approves preferential issue of 5.74 crore warrants to Bajaj Finserv
- Chaman Metallics Limited announces H1 FY27 financial results and proposed Rights Issue
- Harmony Capital Services receives BSE approval for preferential issue of shares
- Kuber Udyog: open offer corrigendum, allotments of shares and warrants at ₹23.10
Potential multibaggers · Q2 FY27
Potential multibaggers in Retailing
on management's own guidance
- Strong growth2
- Strong growth1
- FSN E-CommerceGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.